Matches in Wikidata for { <http://www.wikidata.org/entity/Q98629254> ?p ?o ?g. }
Showing items 1 to 35 of
35
with 100 items per page.
- Q98629254 description "article scientifique publié en 2020" @default.
- Q98629254 description "artículu científicu espublizáu en xunetu de 2020" @default.
- Q98629254 description "bài báo khoa học" @default.
- Q98629254 description "scientific article published on 25 July 2020" @default.
- Q98629254 description "wetenschappelijk artikel" @default.
- Q98629254 description "наукова стаття, опублікована 25 липня 2020" @default.
- Q98629254 name "Durable Complete Response to AMG 655 (Conatumumab) and Vorinostat in a Patient With Relapsed Classical Hodgkin Lymphoma: Extraordinary Response from a Phase 1b Clinical Protocol" @default.
- Q98629254 name "Durable Complete Response to AMG 655 (Conatumumab) and Vorinostat in a Patient With Relapsed Classical Hodgkin Lymphoma: Extraordinary Response from a Phase 1b Clinical Protocol" @default.
- Q98629254 type Item @default.
- Q98629254 label "Durable Complete Response to AMG 655 (Conatumumab) and Vorinostat in a Patient With Relapsed Classical Hodgkin Lymphoma: Extraordinary Response from a Phase 1b Clinical Protocol" @default.
- Q98629254 label "Durable Complete Response to AMG 655 (Conatumumab) and Vorinostat in a Patient With Relapsed Classical Hodgkin Lymphoma: Extraordinary Response from a Phase 1b Clinical Protocol" @default.
- Q98629254 prefLabel "Durable Complete Response to AMG 655 (Conatumumab) and Vorinostat in a Patient With Relapsed Classical Hodgkin Lymphoma: Extraordinary Response from a Phase 1b Clinical Protocol" @default.
- Q98629254 prefLabel "Durable Complete Response to AMG 655 (Conatumumab) and Vorinostat in a Patient With Relapsed Classical Hodgkin Lymphoma: Extraordinary Response from a Phase 1b Clinical Protocol" @default.
- Q98629254 P1433 Q98629254-70BA0F40-A14A-45D3-9D31-64E9A52A0DD4 @default.
- Q98629254 P1476 Q98629254-0BDA1420-7923-4CAE-86B0-682B6CAA4253 @default.
- Q98629254 P2093 Q98629254-3CD68BC9-D535-4E02-AC81-8C1DF4EB0173 @default.
- Q98629254 P2093 Q98629254-8E5AF59E-1C2D-439B-894C-980FE6AEE639 @default.
- Q98629254 P2093 Q98629254-EC85DC86-5005-49AE-8DB6-E2A6149ED50C @default.
- Q98629254 P31 Q98629254-2FA06E7A-650F-4BC9-BEF5-991D3A388E3D @default.
- Q98629254 P356 Q98629254-3B988909-1D0E-4AA4-A93C-CAF63A98BEA3 @default.
- Q98629254 P577 Q98629254-75D24AB4-A2D9-4DBE-BBC3-7C9791E305BB @default.
- Q98629254 P698 Q98629254-23BCC212-ED8C-4871-AB18-44B7D8774B47 @default.
- Q98629254 P921 Q98629254-D3D992F2-DD69-4816-994C-548BBD2FEF3A @default.
- Q98629254 P356 J.CLML.2020.07.012 @default.
- Q98629254 P698 32828719 @default.
- Q98629254 P1433 Q5133774 @default.
- Q98629254 P1476 "Durable Complete Response to AMG 655 (Conatumumab) and Vorinostat in a Patient With Relapsed Classical Hodgkin Lymphoma: Extraordinary Response from a Phase 1b Clinical Protocol" @default.
- Q98629254 P2093 "Elyce Turba" @default.
- Q98629254 P2093 "Lubomir Sokol" @default.
- Q98629254 P2093 "William Paul Skelton" @default.
- Q98629254 P31 Q13442814 @default.
- Q98629254 P356 "10.1016/J.CLML.2020.07.012" @default.
- Q98629254 P577 "2020-07-25T00:00:00Z" @default.
- Q98629254 P698 "32828719" @default.
- Q98629254 P921 Q209369 @default.